Daiwa Securities Group’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-710
| Closed | -$9K | – | 1364 |
|
|
2025
Q4 | $9K | Buy |
710
+117
| +20% | +$1.42K | ﹤0.01% | 1194 |
|
|
2025
Q3 | $7K | Hold |
593
| – | – | ﹤0.01% | 1184 |
|
|
2025
Q2 | $6K | Hold |
593
| – | – | ﹤0.01% | 1150 |
|
|
2025
Q1 | $4K | Hold |
593
| – | – | ﹤0.01% | 1152 |
|
|
2024
Q4 | $5K | Hold |
593
| – | – | ﹤0.01% | 1165 |
|
|
2024
Q3 | $5K | Buy |
593
+186
| +46% | +$1.53K | ﹤0.01% | 1169 |
|
|
2024
Q2 | $3K | Hold |
407
| – | – | ﹤0.01% | 1233 |
|
|
2024
Q1 | $4K | Buy |
407
+145
| +55% | +$1.03K | ﹤0.01% | 1223 |
|
|
2023
Q4 | $1K | Hold |
262
| – | – | ﹤0.01% | 1305 |
|
|
2023
Q3 | $1K | Hold |
262
| – | – | ﹤0.01% | 1267 |
|
|
2023
Q2 | $1K | Hold |
262
| – | – | ﹤0.01% | 1288 |
|
|
2023
Q1 | $1K | Hold |
262
| – | – | ﹤0.01% | 1269 |
|
|
2022
Q4 | $1K | Hold |
262
| – | – | ﹤0.01% | 1283 |
|
|
2022
Q3 | $1K | Hold |
262
| – | – | ﹤0.01% | 1303 |
|
|
2022
Q2 | $1K | Hold |
262
| – | – | ﹤0.01% | 1306 |
|
|
2022
Q1 | $1K | Hold |
262
| – | – | ﹤0.01% | 1320 |
|
|
2021
Q4 | $2K | Hold |
262
| – | – | ﹤0.01% | 1292 |
|
|
2021
Q3 | $3K | Buy |
262
+128
| +96% | +$1.44K | ﹤0.01% | 1218 |
|
|
2021
Q2 | $2K | Hold |
134
| – | – | ﹤0.01% | 1147 |
|
|
2021
Q1 | $2K | Hold |
134
| – | – | ﹤0.01% | 1150 |
|
|
2020
Q4 | $3K | Buy |
+134
| New | +$1.99K | ﹤0.01% | 1093 |
|
|
2019
Q4 | – | Sell |
-268
| Closed | -$1K | – | 1237 |
|
|
2019
Q3 | $1K | Hold |
268
| – | – | ﹤0.01% | 1157 |
|
|
2019
Q2 | $1K | Hold |
268
| – | – | ﹤0.01% | 1184 |
|
|
2019
Q1 | $1K | Buy |
+268
| New | +$1.08K | ﹤0.01% | 1166 |
|
Other funds holding OCUL
DTC
ACA
SR
VA
VCM
